Hepatocyte-derived intrahepatic cholangiocarcinoma requires Yap and Sox9: A clinical and preclinical analysis

被引：0
|
作者：
Monga, Satdarshan
Ko, Sungjin
Molina, Laura
Tao, Junyan
Singhi, Aatur D.
Bell, Aaron
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
582
引用
收藏
页数：1
相关论文
共 13 条
  • [1] Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma
    Matsushima, Hajime
    Kuroki, Tamotsu
    Kitasato, Amane
    Adachi, Tomohiko
    Tanaka, Takayuki
    Hirabaru, Masataka
    Hirayama, Takanori
    Kuroshima, Naoki
    Hidaka, Masaaki
    Soyama, Akihiko
    Takatsuki, Mitsuhisa
    Kinoshita, Naoe
    Sano, Kazunori
    Nishida, Noriyuki
    Eguchi, Susumu
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (12) : 1067 - 1075
  • [2] Therapeutic implication of SOX9 and YAP1 co-repression in advanced intrahepatic cholangiocarcinoma
    Hu, Shikai
    Molina, Laura
    Tao, Junyan
    Liu, Silvia
    Hassan, Mohammed
    Singh, Sucha
    Poddar, Minakshi
    Nejak-Bowen, Kari
    Oertel, Michael
    Raeman, Reben
    Singhi, Aatur
    Bell, Aaron
    Monga, Satdarshan P.
    Ko, Sungjin
    FASEB JOURNAL, 2022, 36
  • [3] ELUCIDATING THE THERAPEUTIC EFFECT OF SOX-9 AND/OR YAP ELIMINATION IN INTRAHEPATIC CHOLANGIOCARCINOMA
    Ko, Sungjin
    Monga, Satdarshan S.
    HEPATOLOGY, 2019, 70 : 1202A - 1202A
  • [4] SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
    Xiaodong Yuan
    Jun Li
    Cédric Coulouarn
    Tao Lin
    Laurent Sulpice
    Damien Bergeat
    Carolina De La Torre
    Roman Liebe
    Norbert Gretz
    Matthias P. A. Ebert
    Steven Dooley
    Hong-Lei Weng
    British Journal of Cancer, 2018, 119 : 1358 - 1366
  • [5] SOX9 expression decreases survival of patients with intrahepatic cholangiocarcinoma by conferring chemoresistance
    Yuan, Xiaodong
    Li, Jun
    Coulouarn, Cedric
    Lin, Tao
    Sulpice, Laurent
    Bergeat, Damien
    De la Torre, Carolina
    Liebe, Roman
    Gretz, Norbert
    Ebert, Matthias P. A.
    Dooley, Steven
    Weng, Hong-Lei
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 1358 - 1366
  • [6] Sox9 IS REQUIRED TO REGULATE YAP-INDUCED HEPATOCYTE PLASTICITY IN LIVER TUMOR
    Liu, Yuchen
    Zhuo, Shu
    Zhou, Yaxing
    Yang, Yingzi
    HEPATOLOGY, 2020, 72 : 243A - 243A
  • [7] Analysis of Sox9 expression in multi-step carcinogenesis and its oncogenic roles in intrahepatic cholangiocarcinoma
    Matsushima, Hajime
    Kuroki, Tamotsu
    Kitasato, Amane
    Adachi, Tomohiko
    Hirabaru, Masataka
    Fujita, Fumihiko
    Kanetaka, Kengo
    Takatsuki, Mitsuhisa
    Kinoshita, Naoe
    Eguchi, Susumu
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E113 - E113
  • [8] SOX9, a highly sensitive and specific marker to discriminate hepatocellular carcinoma from intrahepatic cholangiocarcinoma
    Ding, X.
    Trac, B.
    Duan, X.
    VIRCHOWS ARCHIV, 2019, 475 : S214 - S214
  • [9] Simultaneous Yap and Sox9 repression eliminates Notch-dependent hepatocyte-driven cholangiocarcinogenesis
    Ko, Sungjin
    Molina, Laura
    Tao, Junyan
    Liu, Silvia
    Hassan, Mohammed
    Hu, Shikai
    Nejak-Bowen, Kari
    Oertel, Michael
    Raeman, Reben
    Singhi, Aatur
    Bell, Aaron
    Monga, Satdarshan
    FASEB JOURNAL, 2020, 34
  • [10] Simultaneous Yap and Sox9 Repression Eliminates Notch-Dependent Hepatocyte-Driven Cholangiocarcinogenesis
    Ko, Sungjin
    Hu, Shikai
    Molina, Laura
    Tao, Junyan
    Liu, Silvia
    Hassan, Mohammed
    Singh, Sucha
    Poddar, Minakshi
    Nejak-Bowen, Kari
    Oertel, Michael
    Raeman, Reben
    Singhi, Aatur
    Bell, Aaron
    Monga, Satdarshan Paul
    AMERICAN JOURNAL OF PATHOLOGY, 2020, 190 (12): : S25 - S25
12